Meg sells BDX 116.24: New Chlamydia and Gonorrhea Assays on the BD Viper⢠LT System Receive FDA 510k Clearance
BALTIMORE, July 28, 2014 -- /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec⢠Chlamydia ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home